Important Safety Information

LUMIGAN^® 0.01% and 0.03% (bimatoprost ophthalmic solution) has been reported to cause darkening (pigmentation) of eye color, eyelid skin, and eyelashes as well as increased growth of eyelashes. Pigmentation changes can increase as long as LUMIGAN^® 0.01% and 0.03% is used. After stopping LUMIGAN^® 0.01% and 0.03%, darkening of eye color is likely to be permanent, while darkening of the eyelid skin and eyelash changes may be reversible. The effects of increased darkening beyond 5 years are not known.

When only one eye is treated, there is a possibility of eyelash Welgra changes in the eye treated with LUMIGAN^® 0.01% and 0.03%. These changes may result in differences between the eyes in eyelash length, thickness, darkness, number of eyelashes, and/or direction of eyelash growth. These changes are usually reversible upon stopping LUMIGAN^® 0.01% and 0.03% therapy.

Avoid allowing the tip of the dispensing bottle to touch the eye, anything around the eye, fingers, or any other surface in order to avoid contamination by common bacteria known to cause eye infections. Serious damage to the eye and loss of vision may result from using contaminated solutions.

If you have eye surgery or develop any eye reactions (such as trauma or infection), immediately consult with your physician about continuing the use of LUMIGAN^® 0.01% and 0.03%.

If you wear contact lenses, remove them before using LUMIGAN^® 0.01% and 0.03%. Then wait 15 minutes after using LUMIGAN^® 0.01% and 0.03% before you put your contacts back into your eyes.

The most common side effects are eye redness, growth of eyelashes, and itchy eyes.

There are potential side effects with LUMIGAN^® ophthalmic solution.

You may experience:

• Increased eyelash growth
• Itchy eyes
• Temporary eye redness

Eye redness can occur immediately after use, but usually lasts 4 to 6 weeks. Your eyes may get red, but they typically won't hurt or itch. Call your doctor if they do. Eye redness alone does not mean that your eyes are being harmed. It's important to follow your eye doctor's instructions and continue taking LUMIGAN^® so that you may realize the long-term benefits of managing your IOP.
In clinical studies, approximately 3% of patients taking LUMIGAN^® stopped taking LUMIGAN^® due to eye redness.

What to expect if you experience eye redness with LUMIGAN^®